GlobalData on MSN

Masimo secures FDA approval for OIRD detection on wearable patient monitor

The newly cleared capability uses AI through the smartSET pulse oximetry sensor platform.
Business Wire

Masimo Receives Sustainability Seal of Approval from Practice Greenhealth

IRVINE, Calif. & RESTON, Va.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a leading medical technology innovator, and Practice Greenhealth, a prominent organization dedicated to advancing sustainability ...
Nasdaq

GE HealthCare and Masimo Collaborate to Bring Masimo SET® Pulse Oximetry to the Wireless and Wearable GE HealthCare Portrait Mobile Platform

CHICAGO & IRVINE, Calif.--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) and Masimo (Nasdaq: MASI) today announced a joint agreement to integrate Masimo Signal Extraction Technology® (SET®) pulse ...
FierceBiotech

Masimo paints pulse oximetry tech onto GE HealthCare's Portrait patient monitoring system

The Portrait Mobile system’s around-the-clock readings are meant to be an upgrade to traditional in-hospital monitoring methods, which typically check on patients’ vital signs only once every few ...
Messenger-Inquirer

Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Soo…

Masimo, a Danaher company and a specialty diagnostics solutions innovator of pulse oximetry and other patient monitoring ...
Hosted on MSN

Masimo’s Study on Pulse Oximetry and Skin Pigmentation: A Potential Game-Changer

Masimo Corp. ((MASI)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...